生物信息学
计算生物学
登革热病毒
生物
登革热
体内
基因
微阵列分析技术
体外
微阵列
对接(动物)
青蒿
系统生物学
药品
机制(生物学)
化学
数量结构-活动关系
病菌
药物发现
血浆蛋白结合
分子描述符
登革热出血热
临床疗效
细胞生物学
结合位点
药理学
作者
Mubarak A. Alamri,Mohamed Ahmed Akela
标识
DOI:10.25135/rnp.2607.3985
摘要
Dengue Hemorrhagic Fever (DHF) continues to be a major public health challenge because of its complicated inflammatory mechanism and lack of an antiviral treatment strategy. The current investigation employs a stringent systems biology approach, including network pharmacology, gene expression studies, and molecular modeling, to identify critical genetic targets in DHF and assess the efficacy of compounds derived from Artemisia annua (A. annua) in treating this condition. Microarray analysis of the GSE18090 and GSE51808 datasets identified differentially expressed genes associated with DHF development. In addition, network pharmacology revealed that artemisinin, luteolin, aurantiamide, and artemisitene can be used to regulate the host inflammatory response by targeting key hub proteins AKT1, HSP90AA1, and ESR1. These proteins play an important role in signaling and stress-related processes in the cell and are often targeted by viruses. The identified interaction was confirmed by molecular docking and a 100-ns MD simulation, which showed a stable complex with high binding affinity. The findings indicated a high binding affinity and structural stability of the compounds within the active sites of their respective targets, with minimal RMSD fluctuations throughout the simulation trajectory. Our results suggest that derivatives of A. annua may alleviate DHF-induced hyperinflammation by targeting multiple proteins. Although these computational insights lay a solid groundwork for drug repurposing, further in vitro and in vivo validation is necessary to verify their efficacy and safety profiles.
科研通智能强力驱动
Strongly Powered by AbleSci AI